OncLive SOSS

Authors

Joyce A. O'Shaughnessy

Latest:

Dr. O'Shaughnessy on Key Results From the EMERALD Trial in HR+/HER2- Breast Cancer

Joyce A. O’Shaughnessy, MD, discusses key results from the phase 3 EMERALD trial of elacestrant, and the potential effects of the agent’s approval on the use of oral selective estrogen receptor degraders for hormone receptor–positive, HER2-negative breast cancer.

Joyce A. O'Shaughnessy, MD

Latest:

Unmet Needs and Future Direction in HER2+ Breast Cancer

The panel looks to the future landscape for HER2+ breast cancer, highlighting emerging treatment practices and currently unmet needs.

Joyce A. OShaughnessy, MD, Balor University Medical Center

Joyce A. O'Shaughnessy, MD, Baylor Charles A. Sammons Cancer Center

Latest:

Decision Factors for SubQ Therapy and Unmet Needs

Joyce A. OShaughnessy, MD, Baylor-Sammons Cancer Center

Joyce A. OShaughnessy, MD, Baylor University Medical Center

Joyce A. O'Shaughnessy, MD, US Oncology

Joyce A. O'Shaugnessy, MD, Baylor Charles A. Sammons Cancer Center

Joyce F. Liu, MD, MPH

Latest:

Dr Liu on the Rationale for Targeting Wee1 in Ovarian Cancer

Joyce F. Liu, MD, MPH, discusses the role of Wee1 in cell cycle regulation and the rationale for targeting this protein in ovarian cancer.

Joyce O Shaughnessy, MD, Baylor-Sammons Cancer Center

Latest:

Dr. O'Shaughnessy on the Rationale for the MonarchE Trial in Breast Cancer

Joyce A. O'Shaughnessy, MD, discusses the rationale for the monarchE trial in breast cancer.

Joyce O Shaughnessy, MD, Baylor University Medical Center

Joyce Oâ€™Shaughnessy, MD, Texas Oncology

Latest:

Epigenetic Studies May Unlock Clues to Gene Mutations

Researchers at Roswell Park Cancer Institute are formalizing their epigenetics program across dozens of disease research groups, with the goal of understanding what changes in the epigenome lead to cancer and identifying targeted, personalized ways to address these changes.

Joyce O'Shaughnessy, MD

Latest:

Preoperative Monitoring and Surgical Options for HER2+ Patients

Kandace P. McGuire, MD, provides clinical insights on how patient monitoring practices inform discussions around surgical options, providing the potential for deescalating surgical management.

Joyce OShaughnessy, MD, Baylor Charles A. Sammons Cancer Center

Joyce OShaughnessy, MD, Baylor University Medical Center

Joyce O'Shaughnessy, MD, Baylor University Medical Center Texas Oncology

Joyce O'Shaugnessy, MD, Baylor University Medical Center

Joyce O'Shaugnessy, MD, Baylor University Medical Center Texas Oncology